NCT03371004: DM-CHOC-PEN Plus Radiation for Brain Tumors

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Phase 1
Drug Category: Chemotherapy, Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 21 Years and older (Adult), Senior)
Location of Metastases: Brain
Additional Notes: 

Comments are closed.

Up ↑